Mode
Text Size
Log in / Sign up

Scoping review of factors affecting P100 latency and amplitude in healthy individualsBlur, age, and alcohol change how your brain sees light

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider variables like age, blur, and alcohol when interpreting P100 VEP recordings in healthy individuals.

This scoping review synthesizes evidence from thirty-nine studies to evaluate factors influencing pattern visual evoked potential (VEP) recordings in healthy individuals. The scope covers demographic variables, ocular properties, and acute exposures such as alcohol and caffeine. The review aims to establish reliable local reference standards consistent with ISCEV recommendations by considering these variables for accurate interpretation.

Key findings indicate that P100 latency follows a non-linear trajectory across the lifespan, characterized by shortening during maturation, stabilization in early adulthood, and progressive prolongation after approximately 40 years of age. P100 amplitude generally declined with aging, and women typically demonstrated higher P100 or N75–P100 amplitudes in adult populations. Increasing refractive blur was associated with progressive latency prolongation and amplitude reduction. Acute alcohol intake prolonged P100 latency, whereas moderate caffeine consumption had no significant effect. Ocular dominance showed no clinically meaningful interocular asymmetry, and metabolic disturbances were associated with prolonged latency in selected populations.

The review notes that anthropometric variables demonstrated weak or inconsistent associations with VEP outcomes. The authors highlight methodological heterogeneity as a primary limitation of the included studies. Because the source is a scoping review rather than a primary trial, pooled effect sizes or specific p-values are not reported. The practice relevance emphasizes that consideration of these variables is essential for accurate interpretation of pattern VEP recordings and for establishing reliable local reference standards.

Your eyes are not the only part of your vision system. Your brain must process the image your eyes send. A recent review looked at thirty-nine studies to see what changes this brain signal over time. The signal is called P100. It measures how fast your brain reacts to light. The review found that this reaction time gets faster as you grow up. It stays steady in early adulthood. Then it slows down after age forty. This slowing is a natural part of getting older. It is not a disease. But it is real.

Other factors also change the signal. Looking through blurry glasses makes the brain take longer to react. Drinking alcohol right before the test also slows the reaction. Coffee had no big effect. Being taller or having a bigger head made little difference. Having one eye stronger than the other did not matter much. Some health issues like diabetes can also slow the signal in some people.

This review is a scoping review. It looks at many different studies. The studies used different methods. This mix makes it hard to say exactly how much each factor matters. Still, the main message is clear. To understand your vision test results, doctors must consider your age, your eye clarity, and what you drank recently. Ignoring these things can lead to wrong conclusions about your eye health.

What this means for you:
Blur, age, and alcohol naturally slow the brain signal used to test vision.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundPattern visual evoked potentials (pattern VEP) are widely used for functional assessment of the visual pathways. The P100 component represents the principal clinical parameter owing to its relative interindividual stability and diagnostic value. However, both latency and amplitude are modulated by multiple physiological and environmental factors, which complicates interpretation and the establishment of reliable reference standards. This scoping review aimed to systematically map determinants of P100 parameters in healthy individuals.Main textThe review was conducted in accordance with PRISMA-ScR and Joanna Briggs Institute methodology. Databases were searched for studies published between 2015 and 2025 that examined biological, refractive, anthropometric, metabolic, or environmental influences on pattern VEP parameters in healthy populations. Owing to methodological heterogeneity, findings were synthesized descriptively. Thirty-nine studies met the inclusion criteria. Age emerged as the most consistent determinant of P100 parameters. Latency followed a non-linear trajectory across the lifespan, with shortening during maturation, stabilization in early adulthood, and progressive prolongation after approximately 40 years of age, whereas amplitude generally declined with aging. Sex differences predominantly affected amplitude, with women typically demonstrating higher P100 or N75–P100 amplitudes in adult populations; latency differences were less consistent and often minimal in paediatric cohorts. Retinal image quality exerted a strong dose-dependent effect on P100 parameters: increasing refractive blur and higher-order aberrations were associated with progressive latency prolongation and amplitude reduction, particularly for small check sizes. Ocular dominance showed no clinically meaningful interocular asymmetry. Metabolic disturbances were associated with prolonged latency in selected populations, whereas anthropometric variables such as head size and height demonstrated weak or inconsistent associations. Among environmental factors, acute alcohol intake prolonged P100 latency, while moderate caffeine consumption had no significant effect.ConclusionAge and retinal image quality represent the primary physiological determinants of P100 latency and amplitude in healthy individuals. Most other modifiers exert modest or context-dependent effects. Consideration of these variables is essential for accurate interpretation of pattern VEP recordings and for establishing reliable local reference standards consistent with ISCEV recommendations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.